Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension

Veterinary Journal

Volumn 193, Issue 2, 2012, Pages 420-425

  Tan, Xun ^a   Chai, Juan ^a   Bi, Shi Cheng ^a   Li, Jun Jun ^a   Li, Wen Wen ^a   Zhou, Ji Yong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Broiler chicken; Matrix metalloproteinase 2; Pulmonary arterial hypertension; Pulmonary vascular remodelling; Smooth muscle cell

Indexed keywords

9 OCTADECENOYL N HYDROXYLAMIDE; DOXYCYCLINE; ENDOTHELIN 1; GELATIN; GELATINASE A; HYDROXAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROILER; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE EXPRESSION REGULATION; IN VITRO STUDY; LUNG DISEASE; MATRIX METALLOPROTEINASE 2 GENE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PULMONARY ARTERIOLE HYPERTROPHY; PULMONARY ARTERY; PULMONARY HYPERTENSION; UPREGULATION; ZYMOGRAPHY;

ANIMALS; ARTERIOLES; CHICKENS; DOXYCYCLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIN-1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXAMIC ACIDS; HYPERTENSION, PULMONARY; HYPERTROPHY; LUNG; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE INHIBITORS; MYOCYTES, SMOOTH MUSCLE; POULTRY DISEASES; PULMONARY ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM CHLORIDE;

AVES; GALLUS GALLUS;

EID: 84865861921     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.01.017     Document Type: Article

References (47)

1. Archer S., Rich S. Primary pulmonary hypertension: A vascular biology and translational research "work in progress". Circulation 2000, 102:2781-2791.
2. Asanuma K., Magid R., Johnson C., Nerem R.M., Galis Z.S. Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. American Journal of Physiology Heart and Circulatory Physiology 2003, 284:H1778-H1784.
3. Castro M.M., Rizzi E., Figueiredo-Lopes L., Fernandes K., Bendhack L.M., Pitol D.L., Gerlach R.F., Tanus-Santos J.E. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 2008, 198:320-331.
4. Castro M.M., Tanus-Santos J.E., Gerlach R.F. Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension. Pharmacology Research 2011, 64:567-572.
5. Chen X.Y., Dun J.N., Miao Q.F., Zhang Y.J. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway. Pharmacology 2009, 83:67-79.
6. Cowan K.N., Jones P.L., Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. Journal of Clinical Investigation 2000, 105:21-34.
7. Davie N., Haleen S.J., Upton P.D., Polak J.M., Yacoub M.H., Morrell N.W., Wharton J. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. American Journal of Respiratory and Critical Care Medicine 2002, 165:398-405.
8. Enkvetchakul B., Beasley J., Bottje W. Pulmonary arteriole hypertrophy in broilers with pulmonary hypertension syndrome (ascites). Poultry Science 1995, 74:1677-1682.
9. Ergul A., Portik-Dobos V., Giulumian A.D., Molero M.M., Fuchs L.C. Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. American Journal of Physiology Heart and Circulatory Physiology 2003, 285:H222-H232.
10. Fernandez-Patron C., Radomski M.W., Davidge S.T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circulation Research 1999, 85:906-911.
11. Firth A.L., Mandel J., Yuan J.X. Idiopathic pulmonary arterial hypertension. Disease Modes and Mechanisms 2010, 3:268-273.
12. Frisdal E., Gest V., Vieillard-Baron A., Levame M., Lepetit H., Eddahibi S., Lafuma C., Harf A., Adnot S., Dortho M.P. Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. European Respiratory Journal 2001, 18:838-845.
13. Galie N., Manes A., Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovascular Research 2004, 61:227-237.
14. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., Amento E., Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circulation Research 1994, 75:181-189.
15. Gatzoulis M.A., Alonso-Gonzalez R., Beghetti M. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. European Respiratory Review 2009, 18:154-161.
16. Gomez A.P., Moreno M.J., Iglesias A., Coral P.X., Hernandez A. Endothelin 1, its endothelin type A receptor, connective tissue growth factor, platelet-derived growth factor, and adrenomedullin expression in lungs of pulmonary hypertensive and nonhypertensive chickens. Poultry Science 2007, 86:909-916.
17. Hamal K.R., Wideman R.F., Anthony N.B., Erf G.F. Differential expression of vasoactive mediators in microparticle-challenged lungs of chickens that differ in susceptibility to pulmonary arterial hypertension. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2010, 298:R235-R242.
18. Hanemaaijer R., Koolwijk P., le Clercq L., de Vree W.J., van Hinsbergh V.W. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochemical Journal 1993, 296:803-809.
19. Jeffery T.K., Wanstall J.C. Pulmonary vascular remodeling: A target for therapeutic intervention in pulmonary hypertension. Pharmacology and Therapeutics 2001, 92:1-20.
20. Jo Y.K., Park S.J., Shin J.H., Kim Y., Hwang J.J., Cho D.H., Kim J.C. ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochemical and Biophysical Research Communications 2011, 404:1039-1043.
21. Jonigk D., Golpon H., Bockmeyer C.L., Maegel L., Hoeper M.M., Gottlieb J., Nickel N., Hussein K., Maus U., Lehmann U., Janciauskiene S., Welte T., Haverich A., Rische J., Kreipe H., Laenger F. Plexiform lesions in pulmonary arterial hypertension: Composition, architecture, and microenvironment. American Journal of Pathology 2011, 179:167-179.
22. Julian R.J. Physiological, management and environmental triggers of the ascites syndrome: A review. Avian Pathology 2000, 29:519-527.
23. Julian R.J., Frazier J.A., Goryo M. Right ventricular hypertrophy, right ventricular failure and ascites in broiler chickens caused by amiodarone-induced lung pathology. Avian Pathology 1989, 18:161-173.
24. Lepetit H., Eddahibi S., Fadel E., Frisdal E., Munaut C., Noel A., Humbert M., Adnot S., D'Ortho M.P., Lafuma C. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. European Respiratory Journal 2005, 25:834-842.
25. Li J.C., Pan J.Q., Huang G.Q., Tan X., Sun W.D., Liu Y.J., Wang X.L. Expression of PDGF-beta receptor in broilers with pulmonary hypertension induced by cold temperature and its association with pulmonary vascular remodeling. Research in Veterinary Science 2010, 88:116-121.
26. Moreno de Sandino M., Hernandez A. Pulmonary arteriole remodeling in hypoxic broilers expressing different amounts of endothelial nitric oxide synthase. Poultry Science 2006, 85:899-901.
27. Newby A.C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovascular Research 2006, 69:614-624.
28. Ozyigit M.O., Kahraman M.M., Sonmez G. The identification of matrix metalloproteinases and their tissue inhibitors in broiler chickens by immunohistochemistry. Avian Pathology 2005, 34:509-516.
29. Pan J.Q., Tan X., Li J.C., Sun W.D., Wang X.L. Effects of early feed restriction and cold temperature on lipid peroxidation, pulmonary vascular remodelling and ascites morbidity in broilers under normal and cold temperature. British Poultry Science 2005, 46:374-381.
30. Raiesdana A., Loscalzo J. Pulmonary arterial hypertension. Annals of Medicine 2006, 38:95-110.
31. Risinger G.M., Hunt T.S., Updike D.L., Bullen E.C., Howard E.W. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. Journal of Biological Chemistry 2006, 281:25915-25925.
32. Stenmark K.R., Meyrick B., Galie N., Mooi W.J., McMurtry I.F. Animal models of pulmonary arterial hypertension: The hope for etiological discovery and pharmacological cure. American Journal of Physiology. Lung Cellular and Molecular Physiology 2009, 297:L1013-L1032.
33. Stiebellehner L., Frid M.G., Reeves J.T., Low R.B., Gnanasekharan M., Stenmark K.R. Bovine distal pulmonary arterial media is composed of a uniform population of well-differentiated smooth muscle cells with low proliferative capabilities. American Journal of Physiology. Lung Cellular and Molecular Physiology 2003, 285:L819-L828.
34. Tan X., Liu Y.J., Li J.C., Pan J.Q., Sun W.D., Wang X.L. Activation of PKCα and pulmonary vascular remodelling in broilers. Research in Veterinary Science 2005, 79:131-137.
35. Tan X., Pan J.Q., Li J.C., Liu Y.J., Sun W.D., Wang X.L. L-Arginine inhibiting pulmonary vascular remodelling is associated with promotion of apoptosis in pulmonary arterioles smooth muscle cells in broilers. Research in Veterinary Science 2005, 79:203-209.
36. Tan X., Hu S.H., Wang X.L. Possible role of nitric oxide in the pathogenesis of pulmonary hypertension in broilers. Avian Pathology 2007, 36:261-267.
37. Tan X., Hu S.H., Wang X.L. The effect of dietary l-carnitine supplementation on pulmonary hypertension syndrome mortality in broilers exposed to low temperatures. Journal of Animal Physiology and Animal Nutrition 2008, 92:203-210.
38. Tang W.L., Guo H., Yang J., Chen B., Wang X. Suppression of tissue inhibitors of metalloproteinases may reverse severe pulmonary arterial hypertension. Cytotherapy 2011, 13:499-502.
39. Vu T.H., Werb Z. Matrix metalloproteinases: Effectors of development and normal physiology. Genes and Development 2000, 14:2123-2133.
40. Wang J., Wang X., Xiang R., Sun W. Effect of L-NAME on pulmonary arterial pressure, plasma nitric oxide and pulmonary hypertension syndrome morbidity in broilers. British Poultry Science 2002, 43:615-620.
41. Wang J., Qiao J., Zhao L.H., Li K., Wang H., Xu T., Tian Y., Gao M., Wang X. Proliferation of pulmonary artery smooth muscle cells in the development of ascites syndrome in broilers induced by low ambient temperature. Journal of Veterinary Medicine A 2007, 54:564-570.
42. Wang X., Li K.F., Adams E., Van Schepdael A. Matrix metalloproteinase inhibitors: A review on bioanalytical methods, pharmacokinetics and metabolism. Current Drug Metabolism 2011, 12:395-410.
43. Wideman R.F. Pathophysiology of heart/lung disorders: Pulmonary hypertension syndrome in broiler chickens. World's Poultry Science Journal 2001, 57:289-307.
44. Wideman R.F., Hamal K.R. Idiopathic pulmonary arterial hypertension: An avian model for plexogenic arteriopathy and serotonergic vasoconstriction. Journal of Pharmacological and Toxicological Methods 2011, 63:283-295.
45. Wideman R.F., Chapman M.E., Hamal K.R., Bowen O.T., Lorenzoni A.G., Erf G.F., Anthony N.B. An inadequate pulmonary vascular capacity and susceptibility to pulmonary arterial hypertension in broilers. Poultry Science 2007, 86:984-998.
46. Wideman R.F., Hamal K.R., Bayona M.T., Lorenzoni A.G., Cross D., Khajali F., Rhoads D.D., Erf G.F., Anthony N.B. Plexiform lesions in the lungs of domestic fowl selected for susceptibility to pulmonary arterial hypertension: Incidence and histology. Anatomical Record (Hoboken) 2011, 294:739-755.
47. Zamora M.A., Dempsey E.C., Walchak S.J., Stelzner T.J. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 1993, 9:429-433.